KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
发明人:
CHO, KWANG HYUNKR,조광현,CHOI, MIN SOOKR,최민수,JUE SHICN,주 시
申请号：
KR1020120125565
公开号：
KR1020140059002A
申请日:
2012.11.07
申请国别(地区):
KR
年份:
2014
代理人:
摘要：
The present invention provides an anti-tumor drug comprising, as active ingredients, Wip1 inhibitors and Mdm-2/p53 interaction inhibitors so as to effectively treat malignant tumors. According to an embodiment of the present invention, malignant tumors, such as multidrug-resistant tumors, can be effectively treated which were nearly impossible to treat with conventional anti-cancer drugs.COPYRIGHT KIPO 2014본 발명은 악성종양의 효과적인 치료를 위하여, Wip1 저해제 및 Mdm-2/p53 상호작용 저해제를 유효성분으로 함유하는 종양 치료제를 제공한다.
